In ₹ Crore except Per Share Latest Annual	CRAVATEX FY22	ASIANTNE FY25	BNAGROCHEM FY25	CFEL FY24	Peer Average
Valuation — at last close
P/E	◆ 19.05×	99.78×	—	33.01×	66.39× -71%
P/B	1.98×	◆ 0.33×	—	0.61×	0.47× +322%
EV/EBITDA	-29.48×	87.99×	—	◆ -1039.92×	-475.97× +94%
Market Cap	₹83.6 Cr	₹17.8 Cr	—	₹84.5 Cr	₹51.2 Cr +63%
Profitability
EBITDA Margin	-120.33%	◆ 0.69%	-12.51%	-1.69%	-4.50% -2572%
Net Income Margin	◆ 179.59%	0.35%	6.60%	50.62%	19.19% +836%
Return on Common Equity	◆ 10.41%	0.36%	10.34%	1.85%	4.18% +149%
Return on Capital Employed	-5.82%	◆ 0.62%	-17.55%	-0.16%	-5.70% -2%
Return on Assets	8.15%	0.26%	◆ 8.89%	1.77%	3.64% +124%
Credit & Quality
Total Debt/Equity	0.10×	0.24×	0.14×	◆ 0.03×	0.14× -27%
Interest Coverage	-4.08×	◆ 0.19×	-4.31×	-3.05×	-2.39× -71%
Scale — latest FY
Revenue / Total Income	₹2.4 Cr	₹50.9 Cr	₹299 Cr	₹5.1 Cr	₹118 Cr -98%
Net Income	₹4.4 Cr	₹0.2 Cr	₹19.8 Cr	₹2.6 Cr	₹7.5 Cr -41%
Total Assets	₹53.9 Cr	₹71.7 Cr	₹372 Cr	₹144 Cr	₹196 Cr -73%
EPS	₹16.98	₹0.09	—	₹1.02	₹0.56 +2959%
Book Value per Share	₹163.17	₹27.18	—	₹55.22	₹41.2 +296%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY22 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 85%.